A pilot study with ethyl bis (2,2-dimethyl-1-aziridinyl) phosphinate (AB-163) and radiation therapy
- 1 July 1982
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (7) , 1219-1223
- https://doi.org/10.1016/0360-3016(82)90071-2
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Radiation Therapy for Esophageal CancerSouthern Medical Journal, 1980
- Fundamental questions in the combined use of radiation and chemicals in the treatment of cancerInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Chemical mechanism of the radiation potentiating effects of 2,2-Dimethylaziridine-type antitumor agentsInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Hypoxic cell sensitizers: early or late in fractionated therapy?British Journal of Cancer, 1978
- Carcinoma of the cervix.Present status and futureCancer, 1977
- Synthesis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agentsJournal of Medicinal Chemistry, 1975
- EFFECTIVENESS OF RADIATION THERAPY IN THE TREATMENT OF CARCINOMA OF THE ESOPHAGUSAmerican Journal of Roentgenology, 1970
- Studies on the chemistry, antitumor activity, and pharmacology of ethyl Di-(2,2 -dimethyl)ethylenamido phosphate (AB-163)Journal of Surgical Oncology, 1969
- Synthesis and chemotherapeutic effects of ethyl bis-(2, 2-dimethyl)-ethylenamido phosphate. A preliminary reportJournal of Pharmaceutical Sciences, 1967
- Combined use of AB-132 (Meturedepa, Turloc) and X irradiation in the management of advanced bronchogenic carcinomaCancer, 1964